# Regeneron Pharmaceuticals, Inc.: Form 8-K, filed Aug 19, 2020

- Company: [Regeneron Pharmaceuticals, Inc.](/companies/regn.md) (CIK 872589)
- Form: 8-K
- Filed: 2020-08-19
- Accepted by EDGAR: Aug 19, 2020, 06:00 ET
- Period: 2020-08-18
- Accession: 0001104659-20-096661
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/872589/000110465920096661/tm2028954d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/872589/000110465920096661/

## Items reported

- Item 1.01: Entry into a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/872589/000110465920096661/tm2028954d1_8k.htm

Filed Aug 19, 2020.
Source: SEC EDGAR, the filing index for accession 0001104659-20-096661. Last ingested by Listed: Nov 6, 2026, 16:27 ET. No prices; not investment advice.
